Wu X, Quan D, Li W, Wisskirchen K, et al. Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial. Gut 2025 Aug 12:gutjnl-2025-335456. doi: 10.1136/gutjnl-2025-335456.
PMID: 40803751